methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate

C28H27ClF2N6O4 — CID 155523007

IUPACmethyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate
SMILESCOC(=O)Nc1ccc2c(c1)NC(=O)CC/C=C/C[C@H](N1CCC(c3c(F)ccc(Cl)c3F)NC1=O)c1ncc-2[nH]1
InChIInChI=1S/C28H27ClF2N6O4/c1-41-28(40)33-15-7-8-16-20(13-15)34-23(38)6-4-2-3-5-22(26-32-14-21(16)35-26)37-12-11-19(36-27(37)39)24-18(30)10-9-17(29)25(24)31/h2-3,7-10,13-14,19,22H,4-6,11-12H2,1H3,(H,32,35)(H,33,40)(H,34,38)(H,36,39)/b3-2+/t19?,22-/m0/s1
InChIKeyVVYCRGXPQOKNCU-IVAUAICZSA-N
MW585.01 g/mol
LogP6.06
Rot. Bonds3

About methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate

methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate (PubChem CID 155523007) has the molecular formula C28H27ClF2N6O4 and a molecular weight of 585.01 g/mol. Its IUPAC name is methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate.

Molecular Properties

Compound Namemethyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate
PubChem CID155523007
Molecular FormulaC28H27ClF2N6O4
Molecular Weight585.01 g/mol
Exact Mass584.18
IUPAC Namemethyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate
SMILESCOC(=O)Nc1ccc2c(c1)NC(=O)CC/C=C/C[C@H](N1CCC(c3c(F)ccc(Cl)c3F)NC1=O)c1ncc-2[nH]1
InChIInChI=1S/C28H27ClF2N6O4/c1-41-28(40)33-15-7-8-16-20(13-15)34-23(38)6-4-2-3-5-22(26-32-14-21(16)35-26)37-12-11-19(36-27(37)39)24-18(30)10-9-17(29)25(24)31/h2-3,7-10,13-14,19,22H,4-6,11-12H2,1H3,(H,32,35)(H,33,40)(H,34,38)(H,36,39)/b3-2+/t19?,22-/m0/s1
InChIKeyVVYCRGXPQOKNCU-IVAUAICZSA-N
XLogP6.06
TPSA128.45 Ų
H-Bond Donors4
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms41
Complexity—

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500585.01
LogP ≤ 56.06
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'halogenated_ring_1', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Methyl [(7s)-7-({(2e)-3-[5-Chloro-2-(1h-Tetrazol-1-Yl)phenyl]prop-2-Enoyl}amino)-2-Oxo-1,2,3,4,5,6,7,9-Octahydro-11,8-(Azeno)-1,9-Benzodiazacyclotridecin-14-Yl]carbamate
CID 53341037
Methyl [(4s,8s)-8-({(2e)-3-[5-Chloro-2-(1h-Tetrazol-1-Yl)phenyl]prop-2-Enoyl}amino)-4-Methyl-2-Oxo-1,3,4,5,6,7,8,10-Octahydro-2h-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]carbamate
CID 66743646
7~]Nonadeca-1(18),2,4,6,12,16(19)-hexaen-5-YL)carbamate
CID 66744646
Methyl [(11s)-11-({(2e)-3-[5-Chloro-2-(1h-Tetrazol-1-Yl)phenyl]prop-2-Enoyl}amino)-6-Fluoro-2-Oxo-1,3,4,10,11,13-Hexahydro-2h-5,9:15,12-Di(Azeno)-1,13-Benzodiazacycloheptadecin-18-Yl]carbamate
CID 91666660
Methyl [(3r,7s)-7-({(2e)-3-[5-Chloro-2-(1h-Tetrazol-1-Yl)phenyl]prop-2-Enoyl}amino)-3-Ethyl-2-Oxo-1,2,3,4,5,6,7,9-Octahydro-11,8-(Azeno)-1,9-Benzodiazacyclotridecin-14-Yl]carbamate
CID 137348814
Methyl [(4r,5e,8s)-8-({(2e)-3-[5-Chloro-2-(1h-Tetrazol-1-Yl)phenyl]prop-2-Enoyl}amino)-4-Methyl-2-Oxo-1,3,4,7,8,10-Hexahydro-2h-12,9-(Azeno)-1,10-Benzodiazacyclotetradecin-15-Yl]carbamate
CID 137348815
Onadeca-1(18),2,4,6,16(19)-pentaen-5-YL)carbamate
CID 66744599
methyl [(5E,8S)-8-[(6R)-6-(3-chlorophenyl)-2-oxo-1,3-oxazinan-3-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate
CID 71260387
methyl [(2R,7S)-7-({(2E)-3-[5-chloro-2-(1H-tetrazol-1-yl)phenyl]prop-2-enoyl}amino)-2-(trifluoromethyl)-2,3,4,5,6,7-hexahydro-1H-8,11-epimino-1,9-benzodiazacyclotridecin-14-yl]carbamate
CID 117828744
methyl [(5E,8S)-8-[(4S)-4-(3-chlorophenyl)-2-oxopiperidin-1-yl]-2-oxo-1,3,4,7,8,10-hexahydro-2H-12,9-(azeno)-1,10-benzodiazacyclotetradecin-15-yl]carbamate
CID 139592452
methyl N-[(12E,15S)-18-chloro-15-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16(19)-hexaen-5-yl]carbamate
CID 66743824
methyl N-[(9R,14S)-14-[[(E)-3-[5-chloro-2-(tetrazol-1-yl)phenyl]prop-2-enoyl]amino]-9-(dimethylcarbamoyl)-8,16,18-triazatricyclo[13.2.1.02,7]octadeca-1(17),2(7),3,5,15-pentaen-5-yl]carbamate
CID 68097008

Frequently Asked Questions

What is the IUPAC name of methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate?
The IUPAC name of methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate (CID 155523007) is methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate.
What is the SMILES notation for methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate?
The canonical SMILES for methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate is COC(=O)Nc1ccc2c(c1)NC(=O)CC/C=C/C[C@H](N1CCC(c3c(F)ccc(Cl)c3F)NC1=O)c1ncc-2[nH]1.
What is the InChIKey of methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate?
The InChIKey is VVYCRGXPQOKNCU-IVAUAICZSA-N. The full InChI is InChI=1S/C28H27ClF2N6O4/c1-41-28(40)33-15-7-8-16-20(13-15)34-23(38)6-4-2-3-5-22(26-32-14-21(16)35-26)37-12-11-19(36-27(37)39)24-18(30)10-9-17(29)25(24)31/h2-3,7-10,13-14,19,22H,4-6,11-12H2,1H3,(H,32,35)(H,33,40)(H,34,38)(H,36,39)/b3-2+/t19?,22-/m0/s1.
What are the key properties of methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate?
methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate has a molecular weight of 585.01 g/mol, XLogP of 6.06, 3 rotatable bonds, 4 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for methyl N-[(12E,15S)-15-[4-(3-chloro-2,6-difluorophenyl)-2-oxo-1,3-diazinan-1-yl]-9-oxo-8,17,19-triazatricyclo[14.2.1.02,7]nonadeca-1(18),2(7),3,5,12,16-hexaen-5-yl]carbamate is sourced from PubChem (CID 155523007), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).